EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic drivers of metalloproteinases and metastasis

Marco Seehawer, Kornelia Polyak

Trends in Cell Biology · 2025-12 · 35 (12) · 1054-1067

DOI: 10.1016/j.tcb.2025.02.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2025-12. Verfasst von Marco Seehawer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasm Metastasis, Metalloproteases, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Novartis, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metalloproteinases (MPs) are crucial for development and homeostasis due to their diverse physiological functions, from the cellular to the organismal level. Their activity is tightly regulated at multiple levels, including epigenetic regulation through DNA methylation and histone modifications. Aberrant MP expression can result in pathological events, involving extracellular matrix remodeling, which can facilitate cancer cell invasion and dissemination. As clinical testing of MP inhibitors has been limited by toxicity, alternative approaches are needed. Epigenetically-driven MP expression is often specific to cancer cells, giving an enticing possibility for cancer cell-specific targeting. Moreover, aberrant epigenetic activity can also drive other metastatic events. Therefore, targeting the epigenetic regulators of MP expression may be a promising alternative approach for the prevention and treatment of metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticNeoplasm MetastasisMetalloproteasesNeoplasmsHumansAnimalsDNA MethylationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

MMP inhibitionepigeneticshistone modifying enzymesmetalloproteinasesmetastasis

Substanzen

Metalloproteases

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, M…

Förderung

  • NCI NIH HHS
  • Novartis
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Seehawer, M., & Polyak, K. (2025). Epigenetic drivers of metalloproteinases and metastasis. Trends in Cell Biology, 35(12), 1054-1067. https://doi.org/10.1016/j.tcb.2025.02.010

Vancouver

Seehawer M, Polyak K. Epigenetic drivers of metalloproteinases and metastasis. Trends in Cell Biology. 2025;35(12):1054-1067. doi:10.1016/j.tcb.2025.02.010

BibTeX
@article{Seehawer2025,
  author = {Seehawer, Marco and Polyak, Kornelia},
  title = {Epigenetic drivers of metalloproteinases and metastasis},
  journal = {Trends in Cell Biology},
  year = {2025},
  volume = {35},
  number = {12},
  pages = {1054--1067},
  doi = {10.1016/j.tcb.2025.02.010}
}
Kostenlos starten →